Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation

British Journal of Pharmacology

Volumn 160, Issue 6, 2010, Pages 1399-1407

  Takeda, K ^a   Shiraishi, Y ^a   Matsubara, S ^a   Miyahara, N ^a   Matsuda, H ^a   Okamoto, M ^a   Joetham, A ^a   Gelfand, E W ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

airway hyperresponsiveness; carbocysteine; eosinophils; montelukast; neutrophils

Indexed keywords

CARBOCISTEINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MONTELUKAST; OVALBUMIN; ACETIC ACID DERIVATIVE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; QUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; FEMALE; GOBLET CELL; LUNG ALVEOLUS CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; TH1 CELL; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; BRONCHIAL HYPERREACTIVITY; COMPARATIVE STUDY; DRUG COMBINATION; DRUG POTENTIATION; EOSINOPHIL; IMMUNOLOGY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM;

ACETATES; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CARBOCYSTEINE; DEXAMETHASONE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EOSINOPHILS; FEMALE; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; OVALBUMIN; QUINOLINES;

EID: 77954075135     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00797.x     Document Type: Article

References (32)

1. Aharony D (1998). Pharmacology of leukotriene receptor antagonists. Am J Respir Crit Care Med 157 : S214 S219.
2. Alexander SPH, Mathie A, Peters JA (2009). Guide to receptors and channels (GRAC), 4th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
3. American Lung Association Asthma Clinical Research Centers, Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ et al. (2007). Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 356 : 2027 2039.
4. Brandolini L, Allergretti M, Berdini V, Cervellera MN, Mascagni P, Rinaldi M et al. (2003). Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs). Eur Cytokine Netw 14 : 20 26.
5. Broide DH (2009). Immunomodulation of allergic disease. Annu Rev Med 60 : 279 291.
6. Busse W, Kraft M (2005). Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127 : 1312 1326.
7. Eder W, Ege MJ, von Mutius E (2006). The asthma epidemic. N Engl J Med 355 : 2226 2235.
8. Effros RM, Nagaraj H (2007). Asthma: new developments concerning immune mechanisms, diagnosis and treatment. Curr Opin Pulm Med 13 : 37 43.
9. Eum SY, Maghni K, Hamid Q, Campbell H, Eidelman DH, Martin JG (2003). Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol 28 : 25 32.
10. Frieri M, Therattil J, Wang SF, Huang CY, Wang YC (2003). Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma. Allergy Asthma Proc 24 : 359 366.
11. Garavaglia ML, Bononi E, Dossena S, Mondini A, Bazzini C, Lanata L et al. (2008). S-CMC-Lys protective effects on human respiratory cells during oxidative stress. Cell Physiol Biochem 22 : 455 464.
12. Guizzardi F, Rodighiero S, Binelli A, Saino S, Bononi E, Dossena S et al. (2006). S-CMC-Lys-dependent stimulation of electrogenic glutathione secretion by human respiratory epithelium. J Mol Med 84 : 97 107.
13. Henderson WR Jr., Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F et al. (2002). A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 165 : 108 116. (Pubitemid 34053366)
14. Ishibashi Y, Kobayashi F, Idesawa A, Taniguchi A, Matsuzawa S (2004). Effects of carbocisteine on altered activities of glycosidase and glycosyltransferase and expression of Muc5ac in SO2-exposed rats. Eur J Pharmacol 487 : 7 15.
15. Ishii Y, Kimura T, Morishima Y, Mochizuki M, Nomura A, Sakamoto T et al. (2002). S-carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine. Eur J Pharmacol 449 : 183 189.
16. Ishiura Y, Fujimura M, Yamamori C, Nobata K, Myou S, Kurashima K et al. (2003). Effect of carbocysteine on cough reflex to capsaicin in asthmatic patients. Br J Clin Pharmacol 55 : 504 510.
17. Jayaram L, Pizzichini E, Lemière C, Man SF, Cartier A, Hargreave FE et al. (2005). Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast. Thorax 60 : 100 105.
18. Kanehiro A, Ikemura T, Mäkelä MJ, Lahn M, Joetham A, Dakhama A et al. (2001). Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 163 : 173 184.
19. Kemp JP (2003). Recent advances in the management of asthma using leukotriene modifiers. Am J Respir Med 2 : 139 156.
20. Meliton AY, Munoz NM, Leff AR (2007). Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion. J Allergy Clin Immunol 120 : 1316 1323.
21. Milgrom H (2007). Unfulfilled expectations in asthma. Allergy Asthma Proc 28 : 111 113.
22. Mosser DM, Zhang X (2008). Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226 : 205 218.
23. Prinz I, Gregoire C, Mollenkopf H, Aguado E, Wang Y, Malissen M et al. (2005). The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse alpha beta and gamma delta effector T cells. J Immunol 175 : 713 719.
24. Sade K, Schwartz I, Schwartz D, Wolman Y, Chernichovski T, Fireman E et al. (2003). Effect of montelukast pretreatment on inducible nitric oxide synthase mRNA expression in the lungs of antigen-challenged allergic mice. Clin Exp Allergy 33 : 1741 1746.
25. Solopov VN, Lunichkina IV, Plisko LF, Kolganova NA (1988). Effect of mukodin on indices of mucociliary transport. Ter Arkh 60 : 55 57.
26. Strunk RC, Bacharier LB, Phillips BR, Szefler SJ, Zeiger RS, Chinchilli VM et al. (2008). Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study. J Allergy Clin Immunol 122 : 1138 1144.
27. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC et al. (2005). Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115 : 233 242.
28. Takeda K, Miyahara N, Kodama T, Taube C, Balhorn A, Dakhama A et al. (2005). S-carboxymethylcysteine normalises airway responsiveness in sensitised and challenged mice. Eur Respir J 26 : 577 585.
29. Tamesis GP, Covar RA (2008). Long-term effects of asthma medications in children. Curr Opin Allergy Clin Immunol 8 : 163 167.
30. Tatsumi K, Fukuchi Y, PEACE Study Group (2007). Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 55 : 1884 1886.
31. Wahn U, Dass SB (2008). Review of recent results of montelukast use as a monotherapy in children with mild asthma. Clin Ther 30 : 1026 1035.
32. Wu AY, Chik SC, Chan AW, Li Z, Tsang KW, Li W (2003). Anti-inflammatory effects of high-dose montelukast in an animal model of acute asthma. Clin Exp Allergy 33 : 359 366.